MEP7908A - Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity - Google Patents

Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity

Info

Publication number
MEP7908A
MEP7908A MEP-79/08A MEP7908A MEP7908A ME P7908 A MEP7908 A ME P7908A ME P7908 A MEP7908 A ME P7908A ME P7908 A MEP7908 A ME P7908A
Authority
ME
Montenegro
Prior art keywords
buccal
inflammatory diseases
pharyngeal cavity
against inflammatory
plant mucilage
Prior art date
Application number
MEP-79/08A
Other languages
Bosnian (bs)
Inventor
Anna-Maria Vestweber
Harald Greve
Original Assignee
Clementine Maria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clementine Maria filed Critical Clementine Maria
Publication of MEP7908A publication Critical patent/MEP7908A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Brushes (AREA)

Abstract

Composition (A), in the form of a solid dosage for topical treatment of inflammatory disease of mouth and throat, comprises a combination of at least a mucus drug (I) and/or their extract and at least a local anesthetic (II). ACTIVITY : Antiinflammatory; Antianginal. MECHANISM OF ACTION : None given.
MEP-79/08A 2004-09-22 2005-08-04 Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity MEP7908A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004046267 2004-09-22
DE102004047405 2004-09-28
DE102004050591A DE102004050591A1 (en) 2004-09-22 2004-10-16 Slime drug-based lozenge for inflammatory diseases of the mouth and throat

Publications (1)

Publication Number Publication Date
MEP7908A true MEP7908A (en) 2010-06-10

Family

ID=35355708

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-79/08A MEP7908A (en) 2004-09-22 2005-08-04 Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity

Country Status (11)

Country Link
EP (1) EP1639998B1 (en)
AT (1) ATE375146T1 (en)
DE (2) DE102004050591A1 (en)
ES (1) ES2296020T3 (en)
GE (1) GEP20084392B (en)
HR (1) HRP20080009T3 (en)
ME (1) MEP7908A (en)
PL (1) PL1639998T3 (en)
PT (1) PT1639998E (en)
RS (1) RS50555B (en)
WO (1) WO2006032364A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005017923A1 (en) * 2005-04-18 2007-03-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Stimulant cough medicine
DE102012000976A1 (en) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition for topical treatment
DE102015113521A1 (en) * 2015-08-17 2017-02-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition for the treatment of the throat / throat
FR3093432B1 (en) 2019-03-07 2021-08-27 Cep Anti-aging cosmetic composition
EP4059508A1 (en) * 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341414A (en) * 1964-08-27 1967-09-12 Merck & Co Inc N-cyclohexylsulfamate solubilized medication
CZ280836B6 (en) * 1994-05-31 1996-04-17 Květa Veselá Herbal burnt sugar and process for preparing thereof
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
ATE525061T1 (en) * 2001-02-28 2011-10-15 Axiomedic Ltd SOLID SELF-ADHESIVE COMPOSITIONS FOR THE TOPICAL TREATMENT OF DISORDERS OF THE ORAL MUCOSA
WO2004045537A2 (en) * 2002-11-14 2004-06-03 Zengen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis

Also Published As

Publication number Publication date
EP1639998A1 (en) 2006-03-29
RS50555B (en) 2010-05-07
ATE375146T1 (en) 2007-10-15
DE502005001659D1 (en) 2007-11-22
EP1639998B1 (en) 2007-10-10
WO2006032364A1 (en) 2006-03-30
PL1639998T3 (en) 2008-03-31
PT1639998E (en) 2008-01-21
GEP20084392B (en) 2008-06-10
DE102004050591A1 (en) 2006-04-06
ES2296020T3 (en) 2008-04-16
HRP20080009T3 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
MX2007004495A (en) Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline.
YU35503A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
CO5130028A1 (en) PREVENTION OF MUCOSITY PRODUCTION IN THE RESPIRATORY ROADS BY MANAGING EGFR ANTAGONIC SUBSTANCES
HRP20080009T3 (en) Plant mucilage based lozenges against inflammatory diseases of the buccal and pharyngeal cavity
NO20071795L (en) Octenidine-containing tablets used for inflammatory diseases of the mouth and throat
DE60308647D1 (en) PHARMACEUTICAL FORM FOR MUCOSAL ADMINISTRATION
WO2007125545A3 (en) Transmucosal composition
BRPI0414425A (en) pharmaceutical compositions
DK1829548T3 (en) Use of Pelargonium Extracts in combination with Plantago for the manufacture of a medicament for the treatment of sore throat
TW200630086A (en) Gaba analog prodrug sustained release oral dosage forms
WO2007146805A3 (en) Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
WO2002047667A3 (en) Novel medicament compositions based on anticholinesterase drugs and on a steroid
NO20054767L (en) Compositions comprising apomorphine for lung inhalation
DK1715859T3 (en) Method of treating and diagnosing respiratory disorders in sleep by zonisamide and means for carrying out the method
UY27757A1 (en) MEDICINAL CONTAINING BETAMIMETICS AND A NEW ANTI-POLYNERGIC.
WO2006091841A3 (en) Compositions and their uses directed to il-4r alpha
NO20080244L (en) Dosage control for prasugrel
ATE466574T1 (en) METHODS AND COMPOSITIONS FOR ORAL FTS DELIVERY
WO2010003472A3 (en) Lozenge composition for treating inflammatory diseases of the mouth and pharynx
BRPI0513186A (en) medicinal composition for oral administration
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
UY27564A1 (en) PHARMACEUTICAL COMBINATION
Moss Refinement of velopharyngoplasty in patients with cleft palate by covering the pharyngeal flap with nasal mucosa from the velum'by Stoll C, Hochmuth M, Meister P, Soost F. Journal of Cranio-Maxillofacial Surgery, Vol. 28; 171-175 (2000)
SG163512A1 (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion